SMAD3 and cancer: Pharmacologic and macrophage-specific inhibition of Smad3 not only blocks MNT formation but also markedly alleviates spontaneous nocifensive behavior in tumor-bearing mice, suggesting that targeting MNT may serve as a dual-function strategy to suppress both tumor progression and cancer pain.